Human Exfoliated Deciduous Teeth Stem Cells (SHED)

Human Exfoliated Deciduous Teeth Stem Cells (SHED)

Cat.No.: CSC-C10013

Species: Human

Source: Dental Pulp; Tooth

  • Specification
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C10013
Description
Human Exfoliated Deciduous Teeth Stem Cells (SHED) are isolated from exfoliated deciduous teeth ofyoungdonors. Each vial contains 5 x 10^5 cells and is delivered frozen. These cells are negative for HIV-1, HBV, HCV, mycoplasma, bacteria, yeast, and fungi. Human Exfoliated Deciduous Teeth Stem Cells (SHED) are guaranteed to maintain at least 15 doublings under the cell culture conditions specified by Creative Bioarray.
Species
Human
Source
Dental Pulp; Tooth
Disease
Normal
Quality Control
Cells are negative for bacteria, yeast, fungi, and mycoplasma.
Storage and Shipping
Creative Bioarray ships frozen cells on dry ice. On receipt, immediately transfer frozen cells to liquid nitrogen (-180 °C) until ready for experimental use.
Never can cryopreserved cells be kept at -20 °C
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Exosomes Derived from Dental Pulp Stem Cells Show Different Angiogenic and Osteogenic Properties in Relation to the Age of the Donor

Pharmaceutics | DOI | Paper |

Background

This study investigates whether donor age affects the regenerative properties of exosomes from dental pulp stem cells. Exosomes were isolated from young donors (stem cells from human exfoliated deciduous teeth) and old donors (dental pulp stem cells from permanent teeth), characterized, and applied to bone marrow mesenchymal stem cells in vitro. Young-donor exosomes contained higher levels of osteogenesis- and angiogenesis-related miRNAs and enhanced MSC proliferation, angiogenic factor secretion (VEGF, HGF), and osteogenic gene expression. The findings support cell-free exosome therapy for craniofacial bone regeneration, with young dental pulp sources showing superior bioactivity.

Key Findings

Exosomes from young and old dental pulp donors showed similar size (80–160 nm) and exosome markers CD63, CD81 and CD9. However, exosomes from young donors (exoY) carried higher levels of osteogenesis- and angiogenesis-related miRNAs. When applied to bone marrow MSCs, exoY significantly enhanced proliferation compared with old-donor exosomes at 3, 7 and 10 days. Both exosome types increased paracrine factor secretion, but exoY induced higher VEGF and HGF production, indicating stronger pro-angiogenic activity. ALP activity increased after exosome treatment, with no clear age-related difference. qPCR showed that exoY treatment more strongly promoted osteogenic gene expression. Overall, young dental pulp stem cell-derived exosomes exhibit superior proliferative and pro-angiogenic potential, supporting their use in cell-free bone regeneration strategies.

Contribution

Creative Bioarray provided human exfoliated deciduous teeth stem cells (SHEDs) used as the young donor cell source. These cells enabled isolation of young-donor exosomes and comparison with old-donor dental pulp stem cell exosomes, supporting the study's age-related angiogenic and osteogenic findings.

Evaluation of EXO influence on MSCs
Fig. 1. Evaluation of EXO influence on MSCs

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products